You're living a good life, and you're still depressed. Here's why.

Your brain doesn’t make unlimited serotonin. Instead, it recycles it. When a serotonin molecule does its job and signals mood stability, a transporter protein (SLC6A4) pulls it back into the neuron so it can be used again. This recycling is how your brain maintains steady mood even during stress.

The SLC6A4 5-HTTLPR short allele variant slows this recycling process. Roughly 40% of the population carries at least one short allele. When your SLC6A4 is working slowly, serotonin lingers in the synapse longer than it should, then gets metabolized away entirely instead of recycled, leaving you with chronically low available serotonin.

You feel anxious at baseline. Normal stressors feel overwhelming. Your mood fluctuates more than peers who have efficient recycling. You might cry easily, feel irritable, or have racing thoughts. Medication that prevents serotonin breakdown (SSRIs) often helps because it forces the system to work with what little serotonin you have.

Before serotonin can be recycled, it has to exist. TPH2 is the enzyme that synthesizes serotonin in your brain. It’s the rate-limiting step: if TPH2 is slow, your brain simply cannot make enough serotonin no matter how efficient your recycling is.

TPH2 variants reduce the enzyme’s activity. Roughly 20% of the population carries variants that meaningfully impair production. If you have this variant, your brain is working with a lower serotonin baseline than people without it, and no amount of serotonin reuptake inhibition will fully compensate because the starting amount is too low.

You feel persistently flat or empty, even on good days. Pleasure is muted. Motivation is low. Nothing feels urgent or exciting. You might not be anxious, but you’re not happy either. This is anhedonia, and it often points to TPH2.

When you face a challenge, your body releases dopamine and norepinephrine to focus your attention and drive action. Once the challenge passes, COMT breaks down these stress hormones so you can relax. If COMT works fast, you shift from alert to calm smoothly. If it works slowly, stress hormones linger, keeping you in fight-or-flight mode long after the threat is gone.

The COMT Val158Met slow variant, carried by roughly 25% of the population in homozygous form, reduces enzymatic activity. You clear stress hormones slowly, meaning your nervous system stays elevated even during periods of safety, and your brain interprets low-level stimulation as threat.

You feel anxious, especially around noise, bright lights, or social situations. Your mind races. You overanalyze conversations. You startle easily. You might avoid stimulation because it feels overwhelming. You may notice caffeine makes everything worse. This is because you already have excess dopamine and norepinephrine hanging around.

Depression isn’t just a neurotransmitter problem. It’s also a wiring problem. Your brain must be able to form new connections, strengthen them, and adapt to new patterns. BDNF (brain-derived neurotrophic factor) is the growth factor that enables this. Without sufficient BDNF, your brain gets stuck in depressive thought patterns because it cannot physically rewire itself.

The BDNF Val66Met variant, carried by roughly 30% of the population, reduces BDNF secretion. You have less ability to benefit from new experiences or therapy because your brain is literally less plastic, making it harder for your neural circuits to change.

You might be in therapy and making logical progress but still feel emotionally stuck. Antidepressants help less than they should. Exercise might lift your mood temporarily but not create lasting change. Your brain can recognize intellectually that things are better, but the emotional circuitry doesn’t update. This is why BDNF variants often predict treatment-resistant depression.

If TPH2 is the maker and COMT is the clearer of stress hormones, MAOA is the breaker of all three major mood neurotransmitters. MAOA breaks down serotonin, dopamine, and norepinephrine. Unlike COMT, which primarily affects stress hormones, MAOA affects the baseline neurotransmitters that drive mood and motivation.

The MAOA-L (low activity) variant, present in roughly 30-40% of males and fewer females, slows neurotransmitter breakdown. Your brain accumulates serotonin, dopamine, and norepinephrine, which sounds good but creates instability because these neurotransmitters fluctuate wildly instead of staying steady.

You experience mood swings more than flat depression. You might have periods of unusual irritability, anger, or emotional reactivity followed by crashes. Your emotional response to events is intense and sometimes hard to control. You’re more sensitive to stress. You might have been told you’re “dramatic” or have a difficult temperament, when really your neurotransmitter system is simply running on a more volatile setting.

When you experience stress, your body releases cortisol to help you cope. Cortisol binds to glucocorticoid receptors, which then signal your brain to calm down, creating a feedback loop that ends the stress response. FKBP5 helps cortisol bind to these receptors efficiently. If FKBP5 is working poorly, cortisol cannot signal the “all clear,” and your body stays stressed even after the threat is gone.

The FKBP5 rs1360780 variant, present in roughly 30% of the population, impairs glucocorticoid receptor sensitivity. You have a prolonged cortisol response after stress, meaning your nervous system takes much longer than normal to return to baseline, amplifying the cumulative impact of small daily stressors.

You feel constantly on edge. Small frustrations feel like major threats. You recover slowly from conflict or criticism. You might feel depressed not because something bad happened, but because your cortisol has been chronically elevated for weeks from accumulated low-level stress. Your body is physically exhausted from staying in emergency mode.